Lifeline Biotechnologies ships first MastaScope to Greece
4 April, 2005. RENO, Nevada USA. Lifeline Biotechnologies, Inc.
(OTC:LBTN) announced that its early breast cancer detection microendoscope
system, the MastaScope, has been shipped to Greece.
The company says that it expects this initial shipment will lead to
future sales as Greek doctors there begin to use the system with their
patients and experience the high quality of visualization in the milk ducts
where the majority of the breast cancers originate. MastaScope systems are
being used in Egypt, Croatia, China and Puerto Rico, as well as the United
The Company also reported that management continues to explore business
opportunities that can generate revenues as the company continues to carry
out research and development of its premiere technology, the First Warning
System, an early warning breast cancer detection system.